Novartis India net profit leaps over 5-fold to Rs 4.39 crore in Q1
New Delhi: Drug firm Novartis India on Thursday reported over five-fold jump in net profit at Rs 4.39 crore for the quarter ended June 30, 2020, mainly on account of reduction in expenses.
The company had posted a net profit of Rs 79 lakh in the corresponding period of previous fiscal, Novartis India said in a filing to the BSE.
Revenue from operations stood at Rs 92.46 crore in the quarter under consideration as against Rs 109.31 crore in the same quarter a year ago, it added.
Total expenses of the company were at Rs 93 crore in the quarter under review as against Rs 118.89 crore in April-June quarter a year ago.
Shares of Novartis India on Thursday closed 0.95 per cent lower at Rs 644.40 on the BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.